Astellas drug to treat menopausal hot flashes gets FDA’s green light
HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.
HQ Team April 22, 2023: Record-breaking heat caused by greenhouse gases, ocean heat, and ocean acidification have resulted in glacial melts, a rise.
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
The WHO has told Chinese officials to regularly share specific and real-time data on the Covid-19 pandemic as Beijing eases the world's strictest.
Adani Green Energy has raised a JPY 27.9 billion ($200 million) loan from two Japanese banks to refinance its existing debt.
A new Space Energy Initiative is bringing together the space sector’s governments, research and industry to develop the first orbital demonstrator SBSP (Space-based.
HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling.
HQ team October 12, 2022: Marksans Pharma, a listed company, is set to acquire a manufacturing site of Tevapharm, an Indian subsidiary of.